154 related articles for article (PubMed ID: 38089912)
1. The effect of icotinib or apatinib on the pharmacokinetic profile of oxycodone in rats and the underlying mechanism.
Zhou Q; Ye F; Ye Z; Gao N; Kong Q; Hu X; Qian J; Wu B
PeerJ; 2023; 11():e16601. PubMed ID: 38089912
[TBL] [Abstract][Full Text] [Related]
2. Effect of apatinib on the pharmacokinetics of tramadol and O-desmethyltramadol in rats.
Bao SS; Tang PF; Gao NY; Xiao ZX; Qian JC; Zheng L; Hu GX; Xu HH
PeerJ; 2023; 11():e16051. PubMed ID: 37719112
[TBL] [Abstract][Full Text] [Related]
3. The effect of anlotinib on the pharmacokinetic profile of oxycodone and the underlying mechanism.
Lin G; Ye Z; Gao N; Hu X; Kong Q; Zhang X; Li J
Chem Biol Interact; 2022 Sep; 364():110044. PubMed ID: 35853539
[TBL] [Abstract][Full Text] [Related]
4. The effect of apatinib on pharmacokinetic profile of buspirone both in vivo and in vitro.
Zhang XD; Li YH; Chen DX; You WW; Hu XX; Chen BB; Hu GX; Qian JC
J Pharm Pharmacol; 2020 Oct; 72(10):1405-1411. PubMed ID: 32608074
[TBL] [Abstract][Full Text] [Related]
5. Effects of Avitinib on CYP450 Enzyme Activity in vitro and in vivo in Rats.
Shi Y; Meng D; Wang S; Geng P; Xu T; Zhou Q; Zhou Y; Li W; Chen X
Drug Des Devel Ther; 2021; 15():3661-3673. PubMed ID: 34456561
[TBL] [Abstract][Full Text] [Related]
6. The effect of Resveratrol on the pharmacokinetic profile of tofacitinib and the underlying mechanism.
Ye Z; Hu J; Wang J; Liu YN; Hu GX; Xu RA
Chem Biol Interact; 2023 Apr; 374():110398. PubMed ID: 36773832
[TBL] [Abstract][Full Text] [Related]
7. CYP2D6 gene polymorphism and apatinib affect the metabolic profile of fluvoxamine.
Ye Z; Chen B; Gao N; Kong Q; Hu X; Lu Z; Qian J; Hu G; Cai J; Wu B
Front Pharmacol; 2022; 13():985159. PubMed ID: 36120346
[TBL] [Abstract][Full Text] [Related]
8. The effect of shikonin on the metabolism of lapatinib in vitro, and in vivo.
Hu Y; Xie S; Xia H; Chen J; Yang Y; Zhan R
Toxicol Appl Pharmacol; 2024 Jan; 482():116797. PubMed ID: 38160892
[TBL] [Abstract][Full Text] [Related]
9. Effects of drug-drug interactions and CYP3A4 variants on alectinib metabolism.
Liu YN; Chen J; Wang J; Li Q; Hu GX; Cai JP; Lin G; Xu RA
Arch Toxicol; 2023 Aug; 97(8):2133-2142. PubMed ID: 37209178
[TBL] [Abstract][Full Text] [Related]
10. Effects of myricetin and quercetin on ticagrelor metabolism and the underlying mechanism.
Wang J; Hu Y; Li Q; Liu YN; Lin J; Xu RA
Chem Biol Interact; 2024 Apr; 392():110924. PubMed ID: 38401715
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of the Effects of Apatinib on the Pharmacokinetics of Venlafaxine and O-desmethylvenlafaxine in SD Male Rats by UPLC-MS/MS.
Bao SS; Wen J; Lin QM; Li YH; Huang YG; Zhou HY; Hu GX
Basic Clin Pharmacol Toxicol; 2018 Dec; 123(6):721-726. PubMed ID: 29964362
[TBL] [Abstract][Full Text] [Related]
12. Investigation of the effects of axitinib on the pharmacokinetics of loperamide and its main metabolite N-demethylated loperamide in rats by UPLC-MS/MS.
Lin QM; Pang NH; Li YH; Huang HL; Zhang XD; Hu GX; Wang ZS
Chem Biol Interact; 2019 Sep; 310():108744. PubMed ID: 31299239
[TBL] [Abstract][Full Text] [Related]
13. Inhibitory effect of resveratrol on the pharmacokinetic of ibrutinib by UPLC-MS/MS.
Wen J; Bao SS; Zhang BW; Liu TH; Ou-Yang QG; Cai JP; Zhou HY
Drug Dev Ind Pharm; 2019 Jan; 45(1):27-31. PubMed ID: 30156133
[TBL] [Abstract][Full Text] [Related]
14. The impacts of CYP3A4 genetic polymorphism and drug interactions on the metabolism of lurasidone.
Li Q; Wang J; Wang ZL; Shen Y; Zhou Q; Liu YN; Hu GX; Cai JP; Xu RA
Biomed Pharmacother; 2023 Dec; 168():115833. PubMed ID: 37935069
[TBL] [Abstract][Full Text] [Related]
15. Effects of multidose simvastatin co-administration on pharmacokinetic profile of apatinib in rats by UPLC-MS/MS.
Gao J; Ren H; Feng Z; Chen S; Liang Y; Liu W; Zhou Q; Wang M
Xenobiotica; 2020 Sep; 50(9):1115-1120. PubMed ID: 32150479
[TBL] [Abstract][Full Text] [Related]
16. Inhibitory effect of napabucasin on arbidol metabolism and its mechanism research.
Nie J; Xia H; Liu YN; Yu Y; Xu RA
Front Pharmacol; 2023; 14():1292354. PubMed ID: 38094891
[TBL] [Abstract][Full Text] [Related]
17. In vivo and in vitro metabolism and pharmacokinetics of cholinesterase inhibitor deoxyvasicine from aerial parts of Peganum harmala Linn in rats via UPLC-ESI-QTOF-MS and UPLC-ESI-MS/MS.
Deng G; Liu W; Ma C; Rong X; Zhang Y; Wang Y; Wu C; Cao N; Ding W; Guan H; Cheng X; Wang C
J Ethnopharmacol; 2019 May; 236():288-301. PubMed ID: 30872168
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of herb-drug interaction of ambrisentan with shikonin based on UPLC-MS/MS.
Lan T; Fang P; Ye X; Lan X; Xu RA
Pharm Biol; 2021 Dec; 59(1):1133-1138. PubMed ID: 34410882
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetic interaction between a Chinese herbal formula Huosu Yangwei oral liquid and apatinib in vitro and in vivo.
Fang SQ; Huang J; Zhang F; Ni HM; Chen QL; Zhu JR; Fu ZC; Zhu L; Hao WW; Ge GB
J Pharm Pharmacol; 2020 Jul; 72(7):979-989. PubMed ID: 32285478
[TBL] [Abstract][Full Text] [Related]
20. Studies on the inhibitory effect of isavuconazole on flumatinib metabolism
Liu YN; Xu X; Nie J; Hu Y; Xu X; Xu RA; Du X
Front Pharmacol; 2023; 14():1168852. PubMed ID: 37214442
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
